Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...
End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed. Compared with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Waitlist survival at 90 days improved from 86.5% before ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
Digital ILC 2020: European study reports that prioritizing patients for liver transplantation using MELD-Na could reduce 90-day waiting-list mortality compared with current practice 27 August 2020: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results